AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32674098 — intervention group
Group type: EXPERIMENTAL
Intervention: General Anesthesia
Number of subjects: 25
Study 32674098 — intervention group
Group type: COMPARATOR
Intervention: Spinal Anesthesia
Number of subjects: 25
Study 35342718 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based program integrating animated psychoeducational videos, group discussion, and SGM youth help-seeking brochure.
Number of subjects: 0
Study 35986131 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose of Mothers and Babies (MB) intervention (attendance at >50% of MB sessions)
Number of subjects: 679
Study 35986131 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher dose of Mothers and Babies (MB) intervention
Number of subjects: 679
Study 32379487 — intervention group
Group type: COMPARATOR
Intervention: 1-Hz rTMS
Number of subjects: 31
Study 32379487 — intervention group
Group type: COMPARATOR
Intervention: 10-Hz rTMS
Number of subjects: 31
Study 32379487 — intervention group
Group type: EXPERIMENTAL
Intervention: Sham rTMS
Number of subjects: 31
Study 35533029 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulfonylureas
Number of subjects: 932
Study 35533029 — intervention group
Group type: COMPARATOR
Intervention: Metformin
Number of subjects: 932
Study 34507861 — intervention group
Group type: EXPERIMENTAL
Intervention: V114
Number of subjects: 1202
Study 34507861 — intervention group
Group type: COMPARATOR
Intervention: PCV13
Number of subjects: 1202
Study 32707159 — intervention group
Group type: EXPERIMENTAL
Intervention: Cephalic-phase microvascular response stimulation (CP group)
Number of subjects: 30
Study 32707159 — intervention group
Group type: COMPARATOR
Intervention: Healthy subjects (CP control group)
Number of subjects: 30
Study 36292091 — intervention group
Group type: EXPERIMENTAL
Intervention: Advanced Platelet-Rich Fibrin (A-PRF)
Number of subjects: 18
Study 36292091 — intervention group
Group type: EXPERIMENTAL
Intervention: Factor-Enriched Bone Graft Matrix with Advanced Platelet-Rich Fibrin (A/S-PRF)
Number of subjects: 18
Study 36292091 — intervention group
Group type: EXPERIMENTAL
Intervention: Freeze-Dried Bone Allograft and Crosslinked Collagen Membrane (FDBA/CM)
Number of subjects: 18
Study 36292091 — intervention group
Group type: EXPERIMENTAL
Intervention: Resorbable Collagen Plug (RCP)
Number of subjects: 18
Study 33438072 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin C (1 g per day for 40 days)
Number of subjects: 292
Study 33438072 — intervention group
Group type: COMPARATOR
Intervention: Control group (without vitamin C)
Number of subjects: 292
Study 32641023 — intervention group
Group type: EXPERIMENTAL
Intervention: General practitioner-based follow-up care
Number of subjects: 390
Study 32641023 — intervention group
Group type: COMPARATOR
Intervention: Specialist-based follow-up care (usual care)
Number of subjects: 390
Study 34559946 — intervention group
Group type: EXPERIMENTAL
Intervention: Sedentary time (ST)
Number of subjects: 112
Study 34559946 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-to-vigorous physical activity (MVPA)
Number of subjects: 112
Study 34559946 — intervention group
Group type: EXPERIMENTAL
Intervention: Placental FATP2 expression
Number of subjects: 112
Study 34559946 — intervention group
Group type: EXPERIMENTAL
Intervention: Cord blood leptin
Number of subjects: 112
Study 32912614 — intervention group
Group type: EXPERIMENTAL
Intervention: Letrozole
Number of subjects: 0
Study 32912614 — intervention group
Group type: COMPARATOR
Intervention: Combined metformin and clomiphene citrate
Number of subjects: 0
Study 36214216 — intervention group
Group type: EXPERIMENTAL
Intervention: 225 mg ensovibep
Number of subjects: 12
Study 36214216 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 mg ensovibep
Number of subjects: 12
Study 33721561 — intervention group
Group type: EXPERIMENTAL
Intervention: No chemotherapy (n=644)
Number of subjects: 6693
Study 33721561 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy (n=749)
Number of subjects: 6693
Study 33721561 — intervention group
Group type: COMPARATOR
Intervention: No chemotherapy (n=748)
Number of subjects: 6693
Study 33721561 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy in women aged ≤50 years (n=464)
Number of subjects: 6693
Study 33721561 — intervention group
Group type: COMPARATOR
Intervention: No chemotherapy in women aged ≤50 years (n=464)
Number of subjects: 6693
Study 33721561 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy in women aged >50 years (n=894)
Number of subjects: 6693
Study 33721561 — intervention group
Group type: COMPARATOR
Intervention: No chemotherapy in women aged >50 years (n=894)
Number of subjects: 6693
Study 33721561 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy in node-negative patients (n=699)
Number of subjects: 6693
Study 33721561 — intervention group
Group type: COMPARATOR
Intervention: No chemotherapy in node-negative patients (n=699)
Number of subjects: 6693
Study 33721561 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy in patients with 1-3 positive nodes (n=658)
Number of subjects: 6693
Study 33721561 — intervention group
Group type: COMPARATOR
Intervention: No chemotherapy in patients with 1-3 positive nodes (n=658)
Number of subjects: 6693
Study 33144321 — intervention group
Group type: EXPERIMENTAL
Intervention: S protein native trimer
Number of subjects: 578
Study 33144321 — intervention group
Group type: COMPARATOR
Intervention: N protein assays
Number of subjects: 578
Study 33144321 — intervention group
Group type: COMPARATOR
Intervention: S protein assays
Number of subjects: 578
Study 33144321 — intervention group
Group type: COMPARATOR
Intervention: Anti-N antibodies
Number of subjects: 578
Study 32404126 — intervention group
Group type: EXPERIMENTAL
Intervention: Solution Focused Brief Therapy (SFBT), 2-4 sessions
Number of subjects: 0
Study 32404126 — intervention group
Group type: EXPERIMENTAL
Intervention: Solution Focused Brief Therapy (SFBT)
Number of subjects: 0
Study 32404126 — intervention group
Group type: COMPARATOR
Intervention: Waitlist group
Number of subjects: 0
Study 35770580 — intervention group
Group type: EXPERIMENTAL
Intervention: Ear acupuncture combined with dry cupping
Number of subjects: 198
Study 35770580 — intervention group
Group type: COMPARATOR
Intervention: Ear acupuncture
Number of subjects: 198
Study 33438238 — intervention group
Group type: EXPERIMENTAL
Intervention: Biological determinist message
Number of subjects: 174
Study 33438238 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactionist message
Number of subjects: 174
Study 33438238 — intervention group
Group type: COMPARATOR
Intervention: Control group (unrelated article)
Number of subjects: 174
Study 32530781 — intervention group
Group type: EXPERIMENTAL
Intervention: TLC-NOSF dressings (UrgoStart Plus Pad and UrgoStart Plus Border)
Number of subjects: 1140
Study 35330830 — intervention group
Group type: EXPERIMENTAL
Intervention: Neostigmine (0.2 mg/h for 120 h)
Number of subjects: 167
Study 35330830 — intervention group
Group type: COMPARATOR
Intervention: 0.9% saline (control)
Number of subjects: 167
Study 35330830 — intervention group
Group type: COMPARATOR
Intervention: Control arm
Number of subjects: 167
Study 35330830 — intervention group
Group type: EXPERIMENTAL
Intervention: Neostigmine arm
Number of subjects: 167
Study 35330830 — intervention group
Group type: EXPERIMENTAL
Intervention: Neostigmine arm and Control arm
Number of subjects: 167
Study 35863686 — intervention group
Group type: EXPERIMENTAL
Intervention: AI-assisted colonoscopy
Number of subjects: 3059
Study 32990529 — intervention group
Group type: EXPERIMENTAL
Intervention: Dry Needling (DN)
Number of subjects: 45
Study 32990529 — intervention group
Group type: EXPERIMENTAL
Intervention: Dry Needling with Intramuscular Electrical Stimulation (DN/IMES)
Number of subjects: 45
Study 32048316 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led supportive intervention, details on dosage and duration not specified.
Number of subjects: 0
Study 32048316 — intervention group
Group type: COMPARATOR
Intervention: Care as usual (Control group).
Number of subjects: 0
Study 32971161 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 mg of celery seed, 3 times a day for 6 weeks
Number of subjects: 80
Study 32971161 — intervention group
Group type: COMPARATOR
Intervention: Placebo, 3 times a day for 6 weeks
Number of subjects: 80
Study 32971161 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 mg of celery seed
Number of subjects: 80
Study 32971161 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 32700666 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained indoor residual spraying (IRS) of insecticide since December 2014
Number of subjects: 531
Study 32700666 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained indoor residual spraying (IRS) of insecticide
Number of subjects: 531
Study 35442813 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 52
Study 35442813 — intervention group
Group type: COMPARATOR
Intervention: Psychoeducation Program (PEP)
Number of subjects: 52
Study 33592577 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 valid days of accelerometer wear
Number of subjects: 159
Study 33592577 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 valid days of accelerometer wear
Number of subjects: 159
Study 33592577 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 valid day of accelerometer wear
Number of subjects: 159
Study 33592577 — intervention group
Group type: COMPARATOR
Intervention: ≥4 valid days of accelerometer wear (criterion)
Number of subjects: 159
Study 32801696 — intervention group
Group type: EXPERIMENTAL
Intervention: Dimethicone nanoemulsions (DMNs)
Number of subjects: 0
Study 32801696 — intervention group
Group type: COMPARATOR
Intervention: Traditional dimethicone emulsions
Number of subjects: 0
Study 35852035 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypothermic dialysis (35.5°C)
Number of subjects: 45
Study 35852035 — intervention group
Group type: COMPARATOR
Intervention: Routine dialysis (36.5°C)
Number of subjects: 45
Study 33903890 — intervention group
Group type: EXPERIMENTAL
Intervention: Single hyperbaric oxygen treatment
Number of subjects: 60
Study 33903890 — intervention group
Group type: COMPARATOR
Intervention: Wait condition (Control)
Number of subjects: 60
Study 33858378 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical metagenomics assay
Number of subjects: 159
Study 32885585 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E 1500 IU/day
Number of subjects: 60
Study 32885585 — intervention group
Group type: COMPARATOR
Intervention: Metformin 500 mg thrice daily + 150 mg/day CC for 5 days
Number of subjects: 60
Study 32308903 — intervention group
Group type: EXPERIMENTAL
Intervention: Noninvasive vagal nerve stimulation (n‐VNS)
Number of subjects: 24
Study 34677755 — intervention group
Group type: EXPERIMENTAL
Intervention: WHO Caregiver Skills Training (CST)
Number of subjects: 86
Study 34677755 — intervention group
Group type: COMPARATOR
Intervention: Enhanced treatment-as-usual
Number of subjects: 86
Study 34670665 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisplatin (DDP) at IC50 (3.586 mg/L) for 48 hours
Number of subjects: 0
Study 34670665 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisplatin (DDP) at IC50 (3.586 mg/L) combined with 20 μmol/L PD98059 for 48 hours
Number of subjects: 0
Study 34670665 — intervention group
Group type: COMPARATOR
Intervention: 20 μmol/L PD98059 for 48 hours
Number of subjects: 0
Study 34670665 — intervention group
Group type: COMPARATOR
Intervention: Blank control group
Number of subjects: 0
Study 33217219 — intervention group
Group type: EXPERIMENTAL
Intervention: Genomics-assisted prediction model based on QTLs and KASP markers
Number of subjects: 9422
Study 33217219 — intervention group
Group type: EXPERIMENTAL
Intervention: MdMYB1 marker H162
Number of subjects: 9422
Study 34881557 — intervention group
Group type: EXPERIMENTAL
Intervention: Tai chi intervention for 12 weeks
Number of subjects: 99
Study 34881557 — intervention group
Group type: COMPARATOR
Intervention: Control group with normal dietary and exercise habits
Number of subjects: 99
Study 32252822 — intervention group
Group type: EXPERIMENTAL
Intervention: Mat Pilates
Number of subjects: 42
Study 32252822 — intervention group
Group type: COMPARATOR
Intervention: Aquatic aerobic exercise
Number of subjects: 42
Study 33099054 — intervention group
Group type: EXPERIMENTAL
Intervention: Metacognitive Training (MCT)
Number of subjects: 113
Study 33099054 — intervention group
Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU)
Number of subjects: 113
Study 32019123 — intervention group
Group type: EXPERIMENTAL
Intervention: Women with GDM
Number of subjects: 1031
Study 32019123 — intervention group
Group type: COMPARATOR
Intervention: Women without GDM
Number of subjects: 1031
Study 34705196 — intervention group
Group type: EXPERIMENTAL
Intervention: WeChat-based multimodal psychoeducational intervention (ICARE programme)
Number of subjects: 72
Study 34705196 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 72
Study 33563147 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacotherapies that increase HDL-C concentrations
Number of subjects: 0
Study 33563147 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma HDL-C concentrations
Number of subjects: 0
Study 33563147 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidemiological studies
Number of subjects: 0
Study 33563147 — intervention group
Group type: EXPERIMENTAL
Intervention: Mendelian randomization studies and genome-wide association studies
Number of subjects: 0
Study 32862232 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin 10 mg once daily
Number of subjects: 4304
Study 32862232 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4304
Study 35817294 — intervention group
Group type: EXPERIMENTAL
Intervention: Dyadic CARE
Number of subjects: 0
Study 35817294 — intervention group
Group type: EXPERIMENTAL
Intervention: Supporter-only CARE
Number of subjects: 0
Study 35817294 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 0
Study 33512028 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured group intervention based on pain neuroscience education (PNE) - 7 group sessions of education in neurobiology of pain
Number of subjects: 139
Study 33512028 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured group intervention based on pain neuroscience education (PNE)
Number of subjects: 139
Study 33512028 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (control group)
Number of subjects: 139
Study 34942135 — intervention group
Group type: EXPERIMENTAL
Intervention: Memantine (20 mg/day orally)
Number of subjects: 160
Study 34942135 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 160
Study 33484874 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mW red laser irradiation
Number of subjects: 10
Study 33726841 — intervention group
Group type: EXPERIMENTAL
Intervention: MEDPass administration of ONS (50 ml four times per day)
Number of subjects: 200
Study 33726841 — intervention group
Group type: COMPARATOR
Intervention: Conventional administration of ONS (between meals)
Number of subjects: 200
Study 33726841 — intervention group
Group type: EXPERIMENTAL
Intervention: MEDPass administration of ONS
Number of subjects: 200
Study 35967549 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal Continuous Positive Airway Pressure (NCPAP)
Number of subjects: 960
Study 35967549 — intervention group
Group type: COMPARATOR
Intervention: Nasal Intermittent Positive Pressure Ventilation (NIPPV)
Number of subjects: 960
Study 33094860 — intervention group
Group type: EXPERIMENTAL
Intervention: Open weighing (sharing weight data with patients)
Number of subjects: 216
Study 33094860 — intervention group
Group type: COMPARATOR
Intervention: Blind weighing (not sharing weight data with patients)
Number of subjects: 216
Study 35112592 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative home chest physiotherapy program for one week in addition to the traditional postoperative program
Number of subjects: 100
Study 35112592 — intervention group
Group type: COMPARATOR
Intervention: Traditional postoperative program only
Number of subjects: 100
Study 35112592 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative home chest physiotherapy program
Number of subjects: 100
Study 34238381 — intervention group
Group type: EXPERIMENTAL
Intervention: SLC45A2 rs28777-A allele
Number of subjects: 795
Study 34238381 — intervention group
Group type: EXPERIMENTAL
Intervention: SLC45A2 rs183671-G allele
Number of subjects: 795
Study 34238381 — intervention group
Group type: EXPERIMENTAL
Intervention: TYR rs1042602-A allele
Number of subjects: 795
Study 34238381 — intervention group
Group type: EXPERIMENTAL
Intervention: SLC45A2 rs1126809-A allele
Number of subjects: 795
Study 35322474 — intervention group
Group type: EXPERIMENTAL
Intervention: Erector spinae plane block (20 mL of 0.375% ropivacaine and 0.5 mcg/kg of clonidine)
Number of subjects: 60
Study 35322474 — intervention group
Group type: COMPARATOR
Intervention: Intrathecal morphine (150 mcg preservative-free morphine with 2 mL of normal saline)
Number of subjects: 60
Study 35322474 — intervention group
Group type: EXPERIMENTAL
Intervention: Erector spinae plane block
Number of subjects: 60
Study 35322474 — intervention group
Group type: COMPARATOR
Intervention: Intrathecal morphine
Number of subjects: 60
Study 33065448 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-motor intervention
Number of subjects: 176
Study 34193498 — intervention group
Group type: EXPERIMENTAL
Intervention: 100% platelet-rich plasma (APRP) eye drops for 4 weeks
Number of subjects: 130
Study 34193498 — intervention group
Group type: COMPARATOR
Intervention: 100% serum (AS) eye drops for 4 weeks
Number of subjects: 130
Study 32492824 — intervention group
Group type: EXPERIMENTAL
Intervention: ACE pilot trial
Number of subjects: 38
Study 35751568 — intervention group
Group type: EXPERIMENTAL
Intervention: Estimands framework for factorial trials
Number of subjects: 0
Study 35751568 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjustment for other factors in noncollapsible effect measures
Number of subjects: 0
Study 32718922 — intervention group
Group type: EXPERIMENTAL
Intervention: Care Coordination Redesign (CCR)
Number of subjects: 933
Study 32718922 — intervention group
Group type: COMPARATOR
Intervention: Care Coordination Programme (CCP)
Number of subjects: 933
Study 35977994 — intervention group
Group type: EXPERIMENTAL
Intervention: Eye-tracking Training
Number of subjects: 53
Study 35977994 — intervention group
Group type: COMPARATOR
Intervention: After-school remediation class
Number of subjects: 53
Study 34048275 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemtuzumab ozogamicin (GO)
Number of subjects: 215
Study 34048275 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemtuzumab ozogamicin (GO) and hematopoietic stem cell transplant (HSCT)
Number of subjects: 215
Study 32390703 — intervention group
Group type: EXPERIMENTAL
Intervention: LKB1/STK11 gene sequencing
Number of subjects: 20
Study 32390703 — intervention group
Group type: EXPERIMENTAL
Intervention: Other gene sequencing (APC, AXIN2, BMPR1A, EPCAM, MLH1, MLH3, MSH2, MSH6, MUTYH, PMS1, PMS2, PTEN, SMAD4)
Number of subjects: 20
Study 32390703 — intervention group
Group type: EXPERIMENTAL
Intervention: Colorectal hamartoma polyps with LKB1/STK11 mutations
Number of subjects: 20
Study 36088901 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose tranexamic acid (1,000 mg in total)
Number of subjects: 56
Study 36088901 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose tranexamic acid (500 mg in total)
Number of subjects: 56
Study 36088901 — intervention group
Group type: COMPARATOR
Intervention: Placebo (counterpart saline)
Number of subjects: 56
Study 33456356 — intervention group
Group type: EXPERIMENTAL
Intervention: Three-miRNA signature (hsa-miR-139-3p, hsa-miR-760, hsa-miR-7-5p)
Number of subjects: 344
Study 33456356 — intervention group
Group type: EXPERIMENTAL
Intervention: High-risk score based on three-miRNA signature
Number of subjects: 344
Study 33456356 — intervention group
Group type: EXPERIMENTAL
Intervention: Three-miRNA signature
Number of subjects: 344
Study 33456356 — intervention group
Group type: COMPARATOR
Intervention: hsa-miR-139-3p
Number of subjects: 344
Study 33456356 — intervention group
Group type: COMPARATOR
Intervention: hsa-miR-7-5p and hsa-miR-760
Number of subjects: 344
Study 32885274 — intervention group
Group type: EXPERIMENTAL
Intervention: glasdegib + LDAC
Number of subjects: 116
Study 32885274 — intervention group
Group type: COMPARATOR
Intervention: LDAC alone
Number of subjects: 116
Study 34645657 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated care
Number of subjects: 220
Study 34645657 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 220
Study 32703974 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Functional Training (HIFT)
Number of subjects: 35
Study 32703974 — intervention group
Group type: COMPARATOR
Intervention: Walking at 60% of heart rate reserve (WALK)
Number of subjects: 35
Study 32703974 — intervention group
Group type: COMPARATOR
Intervention: Control group (CON) - physically inactive reading a book
Number of subjects: 35
Study 32703974 — intervention group
Group type: EXPERIMENTAL
Intervention: Trail Making Test
Number of subjects: 35
Study 34914232 — intervention group
Group type: EXPERIMENTAL
Intervention: Microsurgical varicocelectomy followed by oral administration of Danhong Tongjing Prescription (DTP) for 90 days
Number of subjects: 68
Study 34914232 — intervention group
Group type: COMPARATOR
Intervention: Microsurgical varicocelectomy (control group)
Number of subjects: 68
Study 33043615 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelvic external beam radiotherapy (EBRT) with or without vault brachytherapy (VB) boost; 79% recommended for Stage IIIA cases, 77% for IIIC1 cases.
Number of subjects: 65
Study 33043615 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelvic EBRT combined with chemotherapy; 61% for Stage IIIA cases, 88% for IIIC1 cases.
Number of subjects: 65
Study 33043615 — intervention group
Group type: EXPERIMENTAL
Intervention: Vault brachytherapy (VB); recommended when pelvic EBRT was offered for 4 of the 5 case scenarios.
Number of subjects: 65
Study 32075677 — intervention group
Group type: EXPERIMENTAL
Intervention: VITAL Start (video intervention)
Number of subjects: 892
Study 32075677 — intervention group
Group type: COMPARATOR
Intervention: Standard-of-care pre-ART counseling
Number of subjects: 892
Study 36498393 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance exercise training (RET)
Number of subjects: 0
Study 34509031 — intervention group
Group type: EXPERIMENTAL
Intervention: Family Start up Program (FSP)
Number of subjects: 1701
Study 34509031 — intervention group
Group type: COMPARATOR
Intervention: Care as Usual (CAU)
Number of subjects: 1701
Study 35166029 — intervention group
Group type: EXPERIMENTAL
Intervention: Fractional CO2 laser + topical triamcinolone (TA)
Number of subjects: 22